BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
30.53 EUR
+0.17 (+0.56%)
BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. BAYN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BAYN was profitable.
In the past year BAYN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
In the past 5 years BAYN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.25%, BAYN is doing worse than 63.64% of the companies in the same industry.
BAYN has a Return On Equity of -11.25%. This is in the lower half of the industry: BAYN underperforms 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of BAYN has declined.
The Gross Margin of BAYN (54.95%) is worse than 69.09% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
The number of shares outstanding for BAYN remains at a similar level compared to 5 years ago.
BAYN has a better debt/assets ratio than last year.
2.2 Solvency
BAYN has an Altman-Z score of 0.81. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.81, BAYN is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
The Debt to FCF ratio of BAYN is 8.37, which is on the high side as it means it would take BAYN, 8.37 years of fcf income to pay off all of its debts.
BAYN has a Debt to FCF ratio of 8.37. This is in the lower half of the industry: BAYN underperforms 65.45% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that BAYN has dependencies on debt financing.
BAYN has a Debt to Equity ratio (1.04) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.81 |
ROIC/WACCN/A
WACC6.47%
2.3 Liquidity
A Current Ratio of 1.13 indicates that BAYN should not have too much problems paying its short term obligations.
BAYN has a Current ratio of 1.13. This is in the lower half of the industry: BAYN underperforms 67.27% of its industry peers.
BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.73, BAYN is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
The Revenue has decreased by -2.16% in the past year.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
The Earnings Per Share is expected to grow by 3.36% on average over the next years.
Based on estimates for the next years, BAYN will show a small growth in Revenue. The Revenue will grow by 1.49% on average per year.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.72, the valuation of BAYN can be described as very cheap.
Based on the Price/Earnings ratio, BAYN is valued cheaper than 98.18% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, BAYN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.27, the valuation of BAYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 96.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, BAYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.72 | ||
| Fwd PE | 6.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than 78.18% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BAYN is valued cheaper than 98.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.53 | ||
| EV/EBITDA | 9.33 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, BAYN is not a good candidate for dividend investing.
BAYN's Dividend Yield is slightly below the industry average, which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.41, BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
FRA:BAYN (11/27/2025, 5:29:57 PM)
30.53
+0.17 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.99B
Revenue(TTM)46.61B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.58 (-3.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)1.65%
PT rev (3m)1.99%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-5.7%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.72 | ||
| Fwd PE | 6.27 | ||
| P/S | 0.65 | ||
| P/FCF | 6.53 | ||
| P/OCF | 4.2 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.33 |
EPS(TTM)5.34
EY17.49%
EPS(NY)4.87
Fwd EY15.96%
FCF(TTM)4.67
FCFY15.31%
OCF(TTM)7.28
OCFY23.84%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.81 |
F-Score4
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.12%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.69%.